NCT07171359View on ClinicalTrials.gov

TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD)

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Alcohol Use DisorderOpioid Use Disorder
Interventions
DEVICE

TMS Low-Dose

one 3-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

DEVICE

TMS High-Dose

One 9-minute session of TMS TBS delivered each morning, prior to commencement of their regularly scheduled daily therapy activities, for 5 days/week, for a total of four-weeks (20 sessions total).

Trial Locations (1)

97232

Another Chance Drug & Alcohol Rehab Center of Portland, Portland

All Listed Sponsors
lead

Washington State University

OTHER

NCT07171359 - TMS to Improve Recovery Outcomes Among Patients With Opioid Use Disorder (OUD) and Alcohol Use Disorder (AUD) | Biotech Hunter | Biotech Hunter